Case report

FOLFIRI and regorafenib combination therapy with dose escalation of irinotecan as fourth-line treatment for patients with metastatic colon cancer according to UGT1A1 genotyping

Lu CY, Yeh YS, Huang CW, Ma CJ, Yu FJ, Wang JY

OncoTargets and Therapy 2014, 7:2143-2146

Published Date: 21 November 2014